{"transactions":[{"id":3244746,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-27T23:49:20.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021."}],"balance_after":11700,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0001171843-20-001358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001358/ownership.xml","form_type":"4"}},{"id":3244745,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-27T23:49:20.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":881,"price":42.25,"value":37222.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 881 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of the ANIK common stock on February 26, 2020, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":49281,"source":{"system":"sec-edgar","filing":"0001171843-20-001358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001358/ownership.xml","form_type":"4"}},{"id":3244744,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-27T23:49:20.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the first vesting installment of RSUs granted on February 26, 2019."}],"balance_after":50162,"source":{"system":"sec-edgar","filing":"0001171843-20-001358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001358/ownership.xml","form_type":"4"}},{"id":3287192,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-06T22:12:26.000Z","date":"2020-02-04","kind":"tax_withholding","acquired":false,"shares":579,"price":40.59,"value":23501.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an aggregate of 579 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested on February 4, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the closing price of the ANIK common stock on February 4, 2020, the trading day on which the vesting of restricted shares gave rise to tax withholding obligations."}],"balance_after":47162,"source":{"system":"sec-edgar","filing":"0001171843-20-000783","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320000783/ownership.xml","form_type":"4"}},{"id":3376858,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Appreciation Rights","published_at":"2019-11-08T22:40:36.000Z","date":"2019-11-06","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 6, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung exercised stock appreciation rights (\"SARS\") granted on January 26, 2010 vesting in four equal annual installments beginning January 26, 2011 and expiring on January 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2020-01-26","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001171843-19-007390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319007390/ownership.xml","form_type":"4"}},{"id":3376857,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-08T22:40:36.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":20000,"price":59.71,"value":1194200.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On November 8, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung sold 20,000 shares in multiple trades ranging from $59.00 to $60.40, a portion of which sale covered the tax liability associated with the SARs exercise. The price reported above reflects the weighted average sale price. Ms. Cheung undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 8, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung sold 20,000 shares in multiple trades ranging from $59.00 to $60.40, a portion of which sale covered the tax liability associated with the SARs exercise. The price reported above reflects the weighted average sale price. Ms. Cheung undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":47741,"source":{"system":"sec-edgar","filing":"0001171843-19-007390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319007390/ownership.xml","form_type":"4"}},{"id":3376856,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-08T22:40:36.000Z","date":"2019-11-06","kind":"tax_withholding","acquired":false,"shares":3681,"price":60.48,"value":222626.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects 3,681 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 6, 2019."}],"balance_after":67741,"source":{"system":"sec-edgar","filing":"0001171843-19-007390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319007390/ownership.xml","form_type":"4"}},{"id":3376855,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-08T22:40:36.000Z","date":"2019-11-06","kind":"exercise","acquired":true,"shares":35000,"price":6.36,"value":222600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 6, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung exercised stock appreciation rights (\"SARS\") granted on January 26, 2010 vesting in four equal annual installments beginning January 26, 2011 and expiring on January 26, 2020."}],"balance_after":71422,"source":{"system":"sec-edgar","filing":"0001171843-19-007390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319007390/ownership.xml","form_type":"4"}},{"id":3627456,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-28T21:32:17.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":7609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 24, 2018, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 3 and 4."},{"field":"date","element":"transactionDate","label":"F3","text":"On February 27, 2019, the Compensation Committee determined and certified that 53.2% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 2 and 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vest in four equal installments on the following dates: February 27, 2019, January 1, 2020, January 1, 2021, and January 1, 2022."}],"balance_after":7609,"derivative":{"exercise_price":61.47,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":7609},"source":{"system":"sec-edgar","filing":"0001171843-19-001385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001385/ownership.xml","form_type":"4"}},{"id":3627455,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-28T21:32:17.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020."}],"balance_after":9000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001171843-19-001385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001385/ownership.xml","form_type":"4"}},{"id":3672793,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-06T14:15:49.000Z","date":"2019-02-04","kind":"tax_withholding","acquired":false,"shares":607,"price":38.1,"value":23126.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 607 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested in full on February 4, 2019."}],"balance_after":36422,"source":{"system":"sec-edgar","filing":"0001171843-19-000756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319000756/ownership.xml","form_type":"4"}},{"id":3672792,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-06T14:15:49.000Z","date":"2019-02-03","kind":"tax_withholding","acquired":false,"shares":579,"price":37.97,"value":21984.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an aggregate of 579 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested in full on February 3, 2019."}],"balance_after":37029,"source":{"system":"sec-edgar","filing":"0001171843-19-000756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319000756/ownership.xml","form_type":"4"}},{"id":4021797,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-02T21:06:47.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":7788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 27, 2017, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 2 and 3."},{"field":"date","element":"transactionDate","label":"F2","text":"On March 2, 2018, the Compensation Committee determined and certified that 55% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in three equal installments on the following dates: March 2, 2018, January 1, 2019, and January 1, 2020."}],"balance_after":7788,"derivative":{"exercise_price":50.13,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":7788},"source":{"system":"sec-edgar","filing":"0001171843-18-001658","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318001658/formfour.xml","form_type":"4"}},{"id":4088833,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-26T21:06:27.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in four equal annual installments beginning January 24, 2019."}],"balance_after":21400,"derivative":{"exercise_price":61.47,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0001171843-18-000689","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000689/formfour.xml","form_type":"4"}},{"id":4419068,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-28T21:06:13.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, February 4, 2016, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 2 and 3."},{"field":"date","element":"transactionDate","label":"F2","text":"On February 24, 2017, the Compensation Committee determined and certified that 125% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in four equal installments on the following dates: February 24, 2017, January 1, 2018, January 1, 2019 and January 1, 2020."}],"balance_after":11500,"derivative":{"exercise_price":38.11,"expiration_date":"2026-02-03","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001171843-17-001206","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001206/formfour.xml","form_type":"4"}},{"id":4425651,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"exercise","acquired":false,"shares":807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercise of 807 stock options granted on June 7, 2011 that were fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Exercise of 807 stock options granted on June 7, 2011 that were fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.99,"underlying":"Common Stock","underlying_shares":807},"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425650,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"exercise","acquired":false,"shares":4193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercise of 4,193 stock options granted on June 7, 2011 that are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Exercise of 4,193 stock options granted on June 7, 2011 that are fully vested."}],"balance_after":20000,"derivative":{"exercise_price":6.99,"underlying":"Common Stock","underlying_shares":4193},"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425649,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Appreciation Rights","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercise of stock appreciation rights (\"SARS\") granted on January 31, 2008, which vested in full on such date, and expiring on January 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Exercise of stock appreciation rights (\"SARS\") granted on January 31, 2008, which vested in full on such date, and expiring on January 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":10.99,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425648,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":807,"price":49.02,"value":39559.14,"ownership":{"direct":true},"balance_after":37608,"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425647,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":1193,"price":49.05,"value":58516.65,"ownership":{"direct":true},"balance_after":38415,"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425646,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"exercise","acquired":true,"shares":5000,"price":6.99,"value":34950.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Exercise of 4,193 stock options granted on June 7, 2011 that are fully vested."},{"field":"security","element":"securityTitle","label":"F4","text":"Exercise of 807 stock options granted on June 7, 2011 that were fully vested."}],"balance_after":39608,"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425645,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":2000,"price":49.01,"value":98020.0,"ownership":{"direct":true},"balance_after":34608,"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425644,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"tax_withholding","acquired":false,"shares":1117,"price":49.2,"value":54956.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects 1,117 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on February 22, 2017."}],"balance_after":36608,"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4425643,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-24T21:05:19.000Z","date":"2017-02-22","kind":"exercise","acquired":true,"shares":5000,"price":10.99,"value":54950.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Exercise of stock appreciation rights (\"SARS\") granted on January 31, 2008, which vested in full on such date, and expiring on January 31, 2018."}],"balance_after":37725,"source":{"system":"sec-edgar","filing":"0001171843-17-001108","document":"f4_cheung022417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001108/f4_cheung022417.xml","form_type":"4"}},{"id":4475943,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":151338,"kind":"person","name":"Cheung Sylvia","position":1,"cik":"0001572857","reported_name":"Cheung Sylvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T21:07:27.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three equal annual installments beginning January 27, 2018."}],"balance_after":28500,"derivative":{"exercise_price":50.13,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001171843-17-000586","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317000586/formfour.xml","form_type":"4"}}]}